ODI Pharma27. Feb.2 Min.ODI Pharma AB: Updated market and business overview ODI Pharma AB (“ODI” or the “Company”) hereby present an updated overview of its market position and the latest trends observed in the...
ODI Pharma22. Feb.3 Min.ODI Pharma AB: Publication of half-year report 2023/2024ODI Pharma AB (“ODI” or the “Company”) hereby publishes its half-year report for the period July – December 2023. The report is available...
ODI Pharma18. Jan.1 Min.ODI Pharma AB anlitar Pareto Securities AB som likviditetsgarantODI Pharma AB (”ODI Pharma” eller ”Bolaget”) har idag utsett Pareto Securities till likviditetsgarant för Bolagets aktie som är upptagen...
ODI Pharma18. Jan.2 Min.ODI Pharma AB appoints Pareto Securities AB as liquidity providerODI Pharma AB (“ODI Pharma” or the “Company”) has today appointed Pareto Securities as the liquidity guarantor for the Company's shares,...
ODI Pharma15. Dez. 20232 Min.Announcement from the Annual General Meeting in ODI Pharma AB (publ) This is an unofficial translation of a notice to the Annual General Meeting in ODI Pharma AB (publ), originally drafted in Swedish. In...